Gland Pharma informed that it has received establishment inspection report (EIR) from the US drug regulator for its Dundigal facility in Hyderabad, indicating closure of the inspection.

The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...

Decades after scientific evidence first raised alarm, Red 3, as it is also called, is currently used in nearly 3,000 food ...

Indian indices ended in positive territory on Wednesday, led by gains in IT and energy stocks. Both the BSE Sensex and NSE ...

Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...

Testing new antibiotics in India, South Africa or Brazil, where they are needed most, makes scientific sense. But it’s not ...

TUESDAY, Jan. 14, 2025 (HealthDay News) -- A deadly bird flu outbreak has wreaked havoc on U.S. chicken farms, claiming the ...

Aragen, based in Hyderabad, says it will use the funds to boost manufacturing capacity for newer treatment modalities, such ...

U.S. Food and Drug Administration (FDA) officials have uncovered dozens of violations at a McDonald's supplier tied to ...

Biocon’s share price climbed to an intraday high of Rs 377.50 per share in intraday trade on the Bombay Stock Exchange (BSE).

Smart choices help optimize mood, energy levels and overall health, and reduce the surges of sluggishness you feel throughout ...

The report also named about three dozen online retailers that it said are allegedly engaged in selling counterfeit products ...